Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oncorus

Oncorus
2015 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$89.5M LATEST DEAL AMOUNT
18 INVESTORS
Description

Developer of a next-generation immunotherapy platform intended to offer treatment of cancer. The company's platform develops innovative and impactful oncolytic products with unprecedented potential to recruit all arms of the immune system to treat solid tumors, enabling patients to have hope and impactful therapies to treat their cancer.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 50 Hampshire Street
  • Suite 401
  • Cambridge, MA 02139
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oncorus’s full profile, request a free trial.

Oncorus Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 20-Dec-2019 $89.5M 00000 Completed Generating Revenue
2. Early Stage VC (Series A2) 15-Dec-2016 000.00 0000 000.00 Completed Generating Revenue
1. Early Stage VC (Series A1) 19-Jul-2016 $37.2M $37.2M 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Oncorus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-1 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Oncorus Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 00000000 Venture Capital-Backed Ottawa, Canada 00 00000 000000000000 00000
0000000 Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000 000000000000 Formerly VC-backed Geneva, Switzerland 000.00 000000&0 000.00
To view this company’s complete list of competitors, request access »

Oncorus Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Citadel (Hedge Fund) Hedge Fund Minority 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Fosun Industrial Holdings Corporation Minority 000 0000 000000 0
IMM Investment Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Oncorus Executive Team (9)

Name Title Board
Seat
Contact
Info
Theodore Ashburn Ph.D Chief Executive Officer, President and Board Member
John McCabe Chief Financial Officer
Christophe Quéva Ph.D Chief Scientific Officer
Eric Sullivan Senior Vice President, Finance & Operations, Treasurer
Mitchell Finer Ph.D Founder & Executive Chairman

4 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Oncorus Board Members (9)

Name Representing Role Since Contact
Info
Alon Lazarus Ph.D Self Board Member 000 0000
Briggs Morrison MD MPM Capital Board Member 000 0000
Cameron Wheeler Ph.D Deerfield Management Board Member 000 0000
Luke Evnin Ph.D MPM Capital Board Member 000 0000
Mary Fenton Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »